Yesterday the UN’s General Assembly passed a near-unanimous declaration on cutting road-traffic deaths in half.
Cyclospora lab test retraction by FDA does not negate outbreak science.
Buffett’s casino comments raise an uncomfortable truth. Is biotechnology an investment, or is it more of a gambling casino? The honest answer is that it can be either.
New structural variation sequencing reads long stretches of fetal DNA to pinpoint duplications, flips, and rearrangements, revealing which changes truly matter.
Carrie Ann Inaba, longtime Dancing with the Stars judge and former co-host of The Talk, talked about the many challenges she has faced with Sjögren’s disease.
A FDA advisory committee will review evidence surrounding peptides. Experts are concerned there is a paucity of evidence to back their approval for legal compounding.
A physician explains Utah’s program to let an AI chatbot renew prescriptions. Six months of data are now testing doctors, regulators and the FDA.
Smoky and orange skies could be a new normal in the summer months in the Midwest and Northeast U.S., but it isn’t a seasonal occurrence yet.
Record summer heat is transforming vacation into a survival season, severely impacting mental health and productivity.
Eli Lilly’s acquisition of AtaiBeckley for up to $3.8 billion, marks a pivotal moment for psychedelic medicine.